European Archives - Page 297 of 1057 - European Medical Journal

Use of Antifungal Therapeutic Drug Monitoring Needs Improvement

A recent study has found that adherence to antifungal therapeutic drug monitoring is moderate-to-high in patients, although there is room for improvement, largely as a result of long turnaround times and uncertainty surrounding the monitoring process.

COVID-19 Viral Load Peaks Later Now Than Previously

Recent analysis of COVID-19 cases have demonstrated that viral load in Omicron infection peaks later now than it did previously in the pandemic, with older variants of the disease. Read more.

The New Era of Inflammatory Disease Treatment: Anti-TNF Adalimumab Biosimilars

This News Feature explores the impact of anti-TNF biosimilars on global healthcare as a cost-effective solution, enhancing access to treatment options for inflammatory conditions.

Higher Risk of Secondary Cancer in Young Survivors of Melanoma

According to a new study from the University of Missouri, Columbia, USA, paediatric and young adult survivors of cutaneous melanoma are at a higher risk of a second primary cancer. Read more.

Timing of Post-Operative Therapy Affects Risk of Cancer Recurrence

According to a recent study, delays in beginning post-operative radiation therapy can increase the risk of recurrence of Merkel cell carcinoma, the second most deadly form of skin cancer. Read more.

EMJ Oncology 11 [Supplement 4] 2023

Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and the incidence is rising significantly…

The Importance of the Multidisciplinary Team in the Management of Patients with Endometrial Cancer: Interviews with Two Key Opinion Leaders

Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and the incidence is rising significantly…

Live Webinar: How to Translate Science into Patient Care, Long Term Outcomes in Clinical Trials | 13th November 3:00 PM - 4:00 PM GMT

This webinar will explore the impact of long term outcomes in clinical trials on clinical decision making.

Live Webinar: Direct Impact of In-House Rapid Lung NGS on Cancer Patient Outcomes | 21 December 4:00-5:00 PM GMT

In this webinar, Francesco Passiglia, MD, Associate Professor of Medical Oncology. University of Turin will summarize the complex landscape of the NSCLC precision oncology biomarkers and treatments.

Sarcomas Unveiled: Advances in Rare Cancer Care

Brian Van Tine joins Jonathan to provide an overview of his clinical interest in soft tissue and bone sarcomas.